Xeomin 100 unit vials
Ended Awarded
- Contract number
- SPE2DR26F9BL1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,721
Award facts
- Contract value 100% obligated
- $14,720.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $14,720.50 to AmerisourceBergen Drug Corp for 100-unit vials of Xeomin on November 13, 2025, with completion scheduled for December 5, 2025. This firm fixed-price delivery order, issued without set-aside designation, will be performed at the contractor's facility in Conshohocken, Pennsylvania. Xeomin is a botulinum toxin product used for medical and therapeutic applications, and this procurement represents a competitive award reflecting the contractor's capability to meet federal pharmaceutical supply requirements.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.9 billion global pharmaceutical support vehicle extending through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp supplies an extensive range of pharmaceutical products, medical devices, and healthcare commodities to support military healthcare systems and other government agencies. The contract vehicle enables the company to deliver specialized medications and medical supplies across multiple therapeutic domains to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Quick answers
Who was awarded contract SPE2DR26F9BL1?
SPE2DR26F9BL1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR26F9BL1 worth?
The government has obligated $14,721 on SPE2DR26F9BL1.
Is contract SPE2DR26F9BL1 an order under another contract?
Yes. SPE2DR26F9BL1 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9BL1 competed?
The extent of competition for SPE2DR26F9BL1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award